Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-36515889

ABSTRACT

The gut microbiota plays an important role in intestinal immune system development and in driving inflammation. Antibiotic administration for therapeutic purposes causes an imbalance in the gut microbiota. Antimicrobial peptides can regulate the gut microbiota and maintain intestinal homeostasis. The aim of this study was to investigate the anti-inflammatory effects and regulation of the gut microbiota by the orally administered antimicrobial peptide mastoparan X (MPX). In this study, Escherichia coli was used to induce intestinal inflammation, and the results showed that MPX+ E. coli alleviated weight loss and intestinal pathological changes in necropsy specimens of E. coli-infected mice. MPX+ E. coli reduced the serum levels of the inflammation-related proteins interleukin-2, interleukin-6, tumour necrosis factor-α, myeloperoxidase, and lactate dehydrogenase on days 7 and 28. Furthermore, MPX+ E. coli increased the length of villi and reduced the infiltration of inflammatory cells into the jejunum and colon post infection. Scanning electron microscopy and transmission electron microscopy results showed that MPX could improve the morphology of jejunum villi and microvilli and increase tight junction protein levels. 16S rRNA sequencing analysis of caecal content samples showed that the species diversity and richness were lower in the E. coli-infected group. At the genus level, MPX+ E. coli significantly reduced the abundance of Bacteroidales and Alistipes and enhanced the relative abundance of Muribaculaceae. Alpha-diversity analyses (Shannon index) showed that MPX significantly increased the microbial diversity of mice. Overall, this study is the first to investigate the effects of oral administration of MPX on intestinal inflammation and the gut microbiota, providing a new perspective regarding the prevention of enteritis and maintenance of intestinal homeostasis.

2.
Arch Virol ; 163(10): 2877-2881, 2018 Oct.
Article in English | MEDLINE | ID: mdl-29987379

ABSTRACT

Getah virus (GETV), a mosquito-borne virus that mainly infects horses and pigs, has emerged and spread in China. We developed a highly specific and reproducible TaqMan probe-based quantitative reverse transcription PCR (RT-qPCR) assay targeting the non-structural protein 1 of GETV, whose detection limit is 25.5 copies/µL, which is 100-fold higher than that of conventional RT-PCR. RT-qPCR was used to detect GETV RNA in mosquito and animal clinical samples, showing that the accuracy of RT-qPCR was higher than that of conventional RT-PCR. The newly developed RT-qPCR assay may be a useful alternative tool for rapid, simple and specific diagnosis of GETV infection.


Subject(s)
Alphavirus/genetics , Culex/virology , DNA Probes/genetics , RNA, Viral/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Viral Nonstructural Proteins/genetics , Alphavirus/isolation & purification , Animals , Base Sequence , China , Horses , Sus scrofa
3.
Arch Virol ; 162(3): 863-866, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27885561

ABSTRACT

An outbreak of severe pseudorabies virus (PRV) infection in farmed mink occurred in northern China in late 2014, causing significant economic losses in the local fur industry. Here, we report the first case of a PRV outbreak in mink in northeastern China, caused by feeding farmed mink with raw pork or organs contaminated by PRV. Mink infected with virulent PRV exhibited diarrhea, neurologic signs, and higher mortality, which can be misdiagnosed as highly pathogenic mink enteritis virus (MEV), canine distemper virus (CDV), and food poisoning. However, these were excluded as causative agents by PCR or bacteria isolation. The duration of disease was 3-7 days, and the mortality rate was 80-90%. PRV was characterized using indirect immunofluorescence assays (IFA) and electron microscopy (EM). Phylogenetic analysis based on full-length genome sequences and those of individual genes of this novel virus strain showed that it clustered in an independent branch with several other PRV isolates from China.


Subject(s)
Animal Feed/virology , Herpesvirus 1, Suid/isolation & purification , Mink/virology , Pseudorabies/virology , Animal Feed/analysis , Animals , China/epidemiology , Food Contamination/analysis , Herpesvirus 1, Suid/classification , Herpesvirus 1, Suid/genetics , Herpesvirus 1, Suid/physiology , Phylogeny , Pseudorabies/epidemiology , Pseudorabies/transmission , Red Meat/virology , Swine , Swine Diseases/epidemiology , Swine Diseases/virology
4.
Vector Borne Zoonotic Dis ; 16(6): 415-22, 2016 06.
Article in English | MEDLINE | ID: mdl-27027481

ABSTRACT

Batai virus (BATV) is an arthropod-borne single-stranded RNA virus belonging to the genus Orthobunyavirus of the family Bunyaviridae that is primarily transmitted by mosquitoes. Methods for detecting BATV are currently limited to serological surveillance, virus isolation, and conventional reverse transcription-polymerase chain reaction (RT-PCR) assay. In this study, we sought to develop a BATV detection assay that needs no specialized equipment and is highly specific, sensitive, and simple. We first developed and optimized a reverse transcription loop-mediated isothermal amplification (RT-LAMP) for rapid detection of BATV that uses two pairs of primers to amplify a conserved region of the BATV M gene. The optimal reaction conditions for this RT-LAMP BATV detection assay were 40 min at 65°C. The amplification products could be visualized directly for color changes. This RT-LAMP method has a detection limit of 2.86 copies/µL and a sensitivity that was approximately 10- and 100-fold greater than real-time and conventional RT-PCR, respectively. RT-LAMP for BATV detection showed no cross-reactivity with other viruses and its sensitivity was validated with cattle blood and mosquito specimens. Our results suggest that this RT-LAMP method was simpler and faster than conventional RT-PCR or real-time RT-PCR. Moreover, RT-LAMP represents a potential tool to test for BATV in clinical and mosquito samples, especially in rural areas of China. This method also shows promise as a diagnostic tool due to its rapid and sensitive detection without the need for sophisticated equipment or complicated protocols.


Subject(s)
Bunyamwera virus/isolation & purification , Bunyaviridae Infections/veterinary , Cattle Diseases/diagnosis , Culex/virology , Nucleic Acid Amplification Techniques/methods , Animals , Base Sequence , Bunyaviridae Infections/diagnosis , Bunyaviridae Infections/virology , Cattle , Cattle Diseases/blood , Cattle Diseases/virology , Chlorocebus aethiops , Female , Reproducibility of Results , Vero Cells
5.
Protein Expr Purif ; 104: 7-13, 2014 12.
Article in English | MEDLINE | ID: mdl-25218147

ABSTRACT

Gene therapy targeting the brain holds great promise in curing nervous system degenerative diseases in clinical applications. With this in mind, in a previous study a 29 amino-acid peptide derived from the rabies virus glycoprotein (RVG29) with a nonamer stretch of arginine residues (RVG29-9R) at its carboxy-terminus was exploited as a ligand for brain-targeting gene delivery. Importantly, the report demonstrated that the RVG29-9R vector was able to cross the blood-brain barrier. RVG29-9R is currently synthesized by commercial companies with high associated costs. In this study, in order to reduce the costs of producing RVG29-9R, we have expressed and purified 6mg of a recombinant peptide (RVG29-9R-6His) from 0.4g of cultured Escherichia coli. We assessed the physiochemical properties of RVG29-9R-6His, its cytotoxicity, and the in vitro transfection efficiency in Neuro 2a cells (which express the acetylcholine receptor). Our results reveal that the RVG29-9R-6His peptide recognized Neuro 2a cells in a dose-dependent manner and it was also able to bind plasmid DNA and deliver it into the Neuro 2a cells effectively. Therefore, our study has demonstrated that the recombinant RVG29-9R-6His peptide retains the functions of RVG29-9R and so may provide an economically viable and alternative production method for the manufacture of RVG29-9R.


Subject(s)
Glycoproteins/genetics , Peptide Fragments/genetics , Rabies virus/metabolism , Recombinant Fusion Proteins/genetics , Viral Envelope Proteins/genetics , Viral Proteins/genetics , Animals , Cell Line , Cell Survival , DNA/administration & dosage , Humans , Mice , Plasmids , Protein Stability , Recombinant Fusion Proteins/isolation & purification , Recombinant Fusion Proteins/toxicity
6.
Virus Genes ; 48(3): 411-20, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24535572

ABSTRACT

The rabies virus (RABV) G protein is the primary contributor to the pathogenicity and protective immunity of RABV. In this study, we generated a recombinant rCVS-11-G strain containing two copies of the G protein derived from the pathogenic wild-type (wt) CVS-11 strain and based on its infectious clone. Compared with the wtCVS-11 strain, the rCVS-11-G strain possessed a larger virion and 1.4-fold more G protein, but it exhibited a similar growth property to the rCVS-11 strain, including passaging stability in vitro. qPCR results showed that the two G genes were over-expressed in BHK-21 cells infected with the rCVS-11-G strain. However, the rCVS-11-G strain presented an 80 % lower LD50 than the wtCVS-11 strain when intracranially (i.c.) inoculated in adult mice. Adult mice that were either intracranially (i.c.) or intramuscularly (i.m.) inoculated with rCVS-11-G strain developed more acute neurological symptoms and greater mortality than those inoculated with the wtCVS-11 strain. Furthermore, the rCVS-11-G strain was more easily and rapidly taken up by neuroblastoma cells. These data indicated that the rCVS-11-G strain might have increased neurotropism because of the over-expression of the pathogenic G protein. The inactivated rCVS-11-G strain induced significantly higher levels of virus neutralization antibodies and provided better protection from street rabies virus challenge in mice. Therefore, the rCVS-11-G strain may be a promising inactivated vaccine strain due to its better immunogenicity.


Subject(s)
Antibodies, Neutralizing/immunology , Rabies Vaccines/immunology , Rabies virus/immunology , Rabies/immunology , Rabies/prevention & control , Viral Envelope Proteins/immunology , Animals , Antibodies, Viral/immunology , Female , Glycoproteins/administration & dosage , Glycoproteins/immunology , Humans , Mice , Mice, Inbred BALB C , Rabies/virology , Rabies Vaccines/administration & dosage , Rabies Vaccines/genetics , Rabies virus/genetics , Vaccines, Inactivated/administration & dosage , Vaccines, Inactivated/genetics , Vaccines, Inactivated/immunology , Viral Envelope Proteins/administration & dosage , Viral Envelope Proteins/genetics
7.
Virus Res ; 184: 7-13, 2014 May 12.
Article in English | MEDLINE | ID: mdl-24486485

ABSTRACT

Rabies is a fatal central nervous system (CNS) disease caused by the neurotropic rabies virus (RABV). The therapeutic management of RABV infections is still problematic, and novel antiviral strategies are urgently required. We established the RVG-BHK-21 cell line, which expresses RABV glycoprotein on the cell surface, to select aptamers. Through 28 iterative rounds of selection, single-stranded DNA (ssDNA) aptamers were generated by exponential enrichment (SELEX). A virus titer assay and a real-time quantitative reverse transcription PCR (qRT-PCR) assay revealed that four aptamers could inhibit the replication of RABV in cultured baby hamster kidney (BHK)-21 cells. However, the aptamers did not inhibit the replication of other virus, e.g., canine distemper virus (CDV) and canine parvovirus (CPV). In addition, the GE54 aptamer was found to effectively protect mice against lethal RABV challenge. After inoculation with aptamers for 24h or 48h, followed by inoculation with CVS-11, approximately 25-33% of the mice survived. In summary, we selected aptamers that could significantly protect from a lethal dose of RABV in vitro and in vivo.


Subject(s)
Antiviral Agents/isolation & purification , Antiviral Agents/pharmacology , Aptamers, Nucleotide/isolation & purification , Aptamers, Nucleotide/pharmacology , Rabies virus/drug effects , Virus Replication/drug effects , Animals , Antiviral Agents/therapeutic use , Aptamers, Nucleotide/therapeutic use , Cell Line , Chemoprevention/methods , Cricetinae , Disease Models, Animal , Female , Mice, Inbred BALB C , Rabies/prevention & control , Rabies virus/physiology , Real-Time Polymerase Chain Reaction , SELEX Aptamer Technique , Survival Analysis , Viral Load
8.
Virus Res ; 173(2): 398-403, 2013 May.
Article in English | MEDLINE | ID: mdl-23333291

ABSTRACT

Rabies is an acute fatal encephalitis disease that affects many warm-blooded mammals. The causative agent of the disease is Rabies virus (RABV). Currently, no approved therapy is available once the clinical signs have appeared. Aptamers, oligonucleotide ligands capable of binding a variety of molecular targets with high affinity and specificity, have recently emerged as promising therapeutic agents. In this study, sixteen high-affinity single-stranded DNA (ssDNA) aptamers were generated by cell-SELEX. Viral titer assays revealed aptamers could specifically inhibit the replication of RABV in cells but did not inhibit the replication of canine distemper virus or canine parvovirus. In addition, the FO21 and FO24 aptamers, with and without PEGylation, were found to effectively protect mice against lethal RABV challenge. When mice were inoculated with aptamers for 24h prior to inoculation with CVS-11, approximately 87.5% of the mice survived. Here, we report aptamers that could significantly protect the mice from a lethal dose of RABV in vitro and in vivo, as demonstrated by the results for survival rate, weight loss and viral titers. These results indicate that FO21 and FO24 aptamers are a promising agent for specific antiviral against RABV infections.


Subject(s)
Antiviral Agents/administration & dosage , Aptamers, Nucleotide/administration & dosage , Rabies virus/drug effects , Rabies/prevention & control , Virus Replication/drug effects , Animals , Antiviral Agents/pharmacology , Aptamers, Nucleotide/pharmacology , Disease Models, Animal , Distemper Virus, Canine/drug effects , Female , Mice , Mice, Inbred BALB C , Parvovirus, Canine/drug effects , Rabies virus/physiology , Survival Analysis , Viral Load
SELECTION OF CITATIONS
SEARCH DETAIL
...